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Abstract: Introduction: Intimate Partner Violence (IPV) is a global epidemic which 30% of women
experience world-wide. Domestic violence has serious health consequences, with an estimated cost
of 1.7 billion annually to the NHS. However, healthcare professionals remain uncertain on how to
manage IPV. In 2007, the Identification and Referral to Improve Safety (IRIS) was introduced within
primary care to address this shortcoming. The aim of this project is to analyse the impact of IRIS,
whilst discussing the extension into secondary care. Materials and Methods: A literature review was
conducted using PubMed, Cochrane Library and Google scholar. The official IRIS publication list for
randomized controlled trial data. Results: General practices with IRIS displayed a threefold increase
in the identification of IPV and sevenfold increase in referrals. IRIS is cost-effective and under the
NICE threshold of GBP 20,000 per quality-adjusted life year gained. Additionally, a systematic
review illustrated that one in six women presenting to the fracture clinic experienced IPV within the
last year. Conclusions: The implementation of IRIS into general practice proved to be cost-effective.
Orthopaedic fracture clinics are at the forefront of dealing with IPV, and therefore an adapted IRIS
programme within this setting has potential in the prevention of IPV.
Keywords: intimate partner violence; identification and referral to improve safety; sexual health;
domestic violence and abuse; public health; fracture clinic
1. Introduction
1.1. Background
Intimate Partner Violence (IPV) is one of the most common forms of family violence,
along with Domestic Violence and Abuse (DVA) [1]. It includes multiple types of physical,
psychological and sexual abuse, such as physical violence, threats, intimidation, isolation,
emotional abuse, economic coercion, manipulation and the assertion of privilege [1]. IPV
has been found to be a widespread phenomenon in every country around the world [2].
IPV occurs in almost all settings and effects people regardless of race, ethnicity, class,
religious belief, age, immigration status and ability [2]. Even in developed counties such as
the UK, the problem is so common and widespread that it has almost become an invisible
form of crime and an everyday story in many households [2].
DVA has serious health consequences which have been the subject of numerous
studies [3]. DVA is a significant risk factor for many physical and psychological health
problems frequently encountered in primary care setting in UK [4]. It has been estimated
that the cost associated with DVA to NHS is GBP 1.7 billion per year, with the major cost
borne by acute trusts and primary care [5].
The healthcare setting therefore offers a critical and unique opportunity for early
identification and prevention of abuse [6]. The professionals from every aspect of our
healthcare setting have daily contact with patients and are in a privileged position to
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help victims. These are patients whose health is damaged by domestic violence and are
subsequently very likely to face extreme mental and physical injuries [3]. However, it
appears that most healthcare professionals are uncertain on how to deal with domestic
abuse victims [7]. While the guidelines from the National Institute for Health and Care
Excellence (NICE) now recommend that there should be training around domestic violence
at every level, it remains minimal or absent in most medical schools [8].
The principal objective of this study was to review the available literature and present
the findings regarding a new training and support programme called the IRIS. Identification
and Referral to Improve Safety (IRIS) is a training and support programme to improve the
response to DVA in general practice [9]. IRIS was initially carried out as a pragmatic cluster-
randomised trial, but it has now been implemented in over 35 administrative localities in
the UK [10]. The trial and local evaluations of the IRIS implementation showed an increase
in patient referrals from general practice to specialist domestic violence agencies [7]. In the
final part of this report, an attempt will be made to conduct a feasibility study with regard
to introducing IRIS to secondary care.
However, before discussing the IRIS programme and the prevention of IPV, it is
important to recognize the causes of domestic violence, different forms and definitions,
the background and scale of the problem, the impact on society, and the role of health
care professionals.
1.2. Definitions
The terms such as violence against women, domestic violence, domestic abuse, inti-
mate partner violence and gender-based violence are often used without noticing that there
are in fact some subtle differences in what each term describes. It is therefore beneficial to
consider a brief description of these terms.
Domestic violence: ‘Domestic violence is considered to be all acts of physical, sexual,
psychological or economic violence that occur within the family or domestic unit or between
former or current spouses or partners, whether or not the perpetrator shares or has shared
the same residence with the victim’ [11].
Violence against women: ‘Violence against women is understood as a violation of
human rights and a form of discrimination against women and shall mean all acts of gender-
based violence that result in, or are likely to result in, physical, sexual, psychological or
economic harm or suffering to women, including threats of such acts, coercion or arbitrary
deprivation of liberty, whether occurring in public or in private life’ [11].
Gender-based violence: It is recognised that gender-based violence is violence that
is directed at an individual based on their biological sex, gender identity or perceived
adherence to socially defined norms of masculinity and femininity [12]. The United Nations
Declaration on the Elimination of Violence against Women (1993) describes violence against
women as: ‘any act of gender-based violence that results in, or is likely to result in, physical,
sexual or psychological harm or suffering to women, including threats of such acts, coercion
or arbitrary deprivation of liberty, whether occurring in public or in private life’ [12]. This
incorporates many forms of abuse that occur throughout the life cycle, including within
the family and within communities [12]. The types of gender-based violence include:
rape and sexual assault; sexual harassment and intimidation at work and other settings;
childhood sexual abuse; domestic abuse; stalking; harmful traditional practices such as
early and forced marriage; so-called ‘honour’ based violence and female genital mutilation;
sex trafficking; and commercial sexual exploitation [12].
Intimate Partner Violence (IPV): The World Health Organisation defines Intimate
Partner Violence (IPV) as a ‘behaviour by an intimate partner or ex-partner that causes
physical, sexual or psychological harm, including physical aggression, sexual coercion,
and psychological abuse and controlling behaviours’ [1]. The concept of physical and
sexual abuse is easily defined but psychological harm has a much broader definition
which includes coercive and controlling behaviour. Coercive behaviour is a type of abuse
which includes threats, blackmailing, humiliation and intimidation [13]. This behaviour is
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intended to harm, punish or frighten the victim [13]. Controlling behaviour is a range of
acts designed to make the victim subordinate and isolate them from sources of support [13].
This enables the perpetrator to exploit their resources and capacities for personal gain by
depriving them of independence and escape [13].
The study presented here focuses specifically on domestic abuse against women when
the perpetrator is a current or previous partner. The terms Intimate Partner Violence
(IPV) and Domestic Violence Abuse (DVA) are therefore used in this context throughout
this report.
1.3. Scale of the Problem
Numerous studies have reported IPV to be a global problem in developing and
developed countries. In order to have a better understanding of the degree and severity of
the problem, it is worth considering some of the published data with regards to the level of
intimate partner violence recorded around the world. It is reported that:
• Globally the lifetime prevalence of physical and sexual intimate partner violence and
abuse for women is around 30% [14].
• In the United States findings from the 1998 National Violence Against Women Survey
showed that 1.5 million women are raped or physically assaulted by an intimate
partner annually [15]. In addition, only 36% of the women injured during their most
recent rape and 30% of the women injured during their most recent physical assault
received some type of medical treatment [15]. Other studies found an incidence of
battering from 7% to 44%, depending on the sampled population [15].
• Across Europe, an average of 22% of women report experiencing physical and/or
sexual violence and that 43% have experienced psychological abuse from the age of
15 [16]. A total of 58% of women across Europe who did not feel that they had an
equal say in household finances experienced psychological abuse compared to 22% of
women who believed that they had an equal say [16].
• In the UK, the reported rate of physical and/or sexual violence was 29% and psycho-
logical abuse 46% [17]. Out of the reported crimes, 25% of women had reported the
most serious incident of intimate partner violence and abuse [17]. However, women
are more likely to contact healthcare services about the most serious incident of abuse
they had experienced [17].
• In Scotland in 2018/19, 60,641 incidents were reported to police [18]. Of these, 82%
were reported as a female victim and male perpetrator [18]. In contrast, male victims
and female perpertrator accounted for 16% of cases [18].
• In England and Wales between 2019/2020 the crime survery estimates that 2.3 million
adults aged 16–74 years experienced domestic abuse.
It is a well-established fact that IPV cuts across all levels of society, social divisions and
can affect everyone [2]. Furthermore, acts of violence against women are not isolated events
but rather patterns of behaviour that violate their human rights [2]. The consequence of
abuse is severe, limiting female participation within society by damaging their health and
well-being [2]. However, there is variation within the prevalence of violence between
different cultures, communities and regions [14]. This shows domestic abuse is not an
inevitable part of life or society, and it should not be treated as such [2]. Violence against
women is not a minor issue that occurs on a small scale within pockets of society [2].
Instead, it is a global epidemic which is not being addressed [2]. As mentioned above
global statistics show that 30% of all women who have been in a relationship will have
experienced physical or sexual violence by their intimate partner [14].
However, it must be said it is not just women that are affected [8]. In the United
Kingdom, as well as the 30% of women, 17.0% of men will have experienced domestic
violence at some point [8]. It is therefore important to recognise that men can, and do, also
experience violence.
Notwithstanding this fact, it is self-evident that, the degree and severity of violence,
particularly sexual violence, perpetrated against women within intimate relationships
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is greater. It is for this reason that the primary focus of this study is on domestic abuse
against women.
1.4. The Causes of Intimate Partner Violence and Abuse
There have been a countless number of research articles to determine the causes of
domestic violence. All of these studies point to many causes. However, all of these causes
have one underlying commonality: the abuser feels the need to exert complete control over
their partner [19]. There is an indication that this ‘need’ originates from a combination of
both environmental and individual factors [19]. The abuser learns to use abusive tactics to
control others from the influence of family members, peers, and cultural traditions, as they
age from a child to an adult [19].
It has been said that intimate partner violence and abuse against women is the outcome
of a dynamic interaction of risk and protective factors that range from broad social factors
to individual risk factors [20]. An explanatory ecological model from the World Health
Organisation may be utilised to understand this concept further [20]. It has been suggested
that, globally, two factors related to gender inequality are strongly associated with intimate
partner violence and abuse [20]. Firstly, the unequal position of women in relationships and
society [20]. This proposition appears to correlate well with the level violence in different
societies [20]. Violence is greater in societies in which men are viewed as superior and
possess the economic and decision-making power [20]. Another factor relates to the social
norms, which sadly states that violence is a means of resolving conflict [20].
It may be worth noting that the literature review carried out for this report indicated
that the experts do not agree on the exact underlying causes of domestic violence, but they
do agree that the victim never asks for or causes domestic abuse. The abuser gains control
over the victim by gradually eroding their self-esteem and sense of autonomy [19]. They
often convince the victim that they deserve the abuse or provoked it in some way [19].
This represents a typical control tactic of abusers—convincing the victim that they bring
it upon themselves and they are at blame for the violence [19]. However, this is not the
case [19]. The victims are not at fault for the abuse and the abuser is responsible for their
behaviour [19].
1.5. Financial Impact of DVA
DVA can result in a range of negative and harmful effects on the health, well-being
and outcomes in the life of women and their family, particularly their children [3]. In this
section of the report, key points regarding the consequences of domestic violence such as
financial cost to the health service and impact on physical and mental health are discussed.
DVA is a significant socio-economic issue which impacts individuals, relatives of
individuals and government services [3]. A multi-country study from the World Health
Organisation displayed that there is a long-term detrimental impact of DVA on health
and well-being [4]. Furthermore, the long-term negative health impact that victims of
IPV experience remains long after the abuse has ended [3]. This leads to a higher use
of government services such as healthcare, criminal justice, and social services [21]. For
example, a Canadian based study found that DVA victims were three times more likely to
access emergency health services than women who had not previously experienced any
abuse [22]. As a result, DVA is extremely expensive for the economy and the healthcare
system within the United Kingdom [21]. The social and economic cost of domestic violence
in the UK from 2016/17 is estimated to be GBP 66 billion [5].
1.6. Physical Impact of DVA
Although the physical signs of DVA may be subtle, there has been increased evidence
from research which suggests that victims of DVA are more likely to experience physical
symptoms [3]. The types of symptoms experienced are associated with the type of abuse
received [22]. For example, sexual abuse is strongly correlated with gynaecological prob-
lems [22]. It is difficult to accurately differentiate which branch of DVA is causing the
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symptoms as there is much overlap [3]. However, studies have clearly demonstrated that
survivors of DVA were much more likely to experience long-term physical problems such
as gastroenterological symptoms, chronic pain and gynaecological disorders [4]
Gynaecological problems are the most common and longest lasting physical health
effect of domestic violence amongst women [3]. In the United Kingdom, a study showed
that 21% of women attending a gynaecological outpatient clinic had previously experienced
domestic violence [22]. The women with a history of domestic violence experienced more
gynaecological symptoms than women with no history of DVA [22]. The gynaecological
symptoms frequently experienced were lower abdominal pain, dyspareunia and dysmen-
orrhoea [22]. There was also an increase in smear abnormalities which could suggest an
increase in cervical cancer [22]. As a result, there was a significant increase in the number
of further gynaecological appointments booked by DVA victims [22].
Domestic abuse often has a major impact on pregnancy and the outcome of preg-
nancy [23]. The annual prevalence of IPV towards a pregnant woman in the UK is estimated
to be 6.4% [3]. However, pregnancy within the past 12 months doubled the risk of physical
violence [24]. IPV during pregnancy is associated with negative health behaviours, physical
and mental health issues and thus a worsened neonatal health outcome [2]. Victims were
more likely to smoke, drink alcohol and use illicit substances throughout the pregnancy [2].
For example, pregnant women who had experienced IPV within the last 12 months were
2.6× more likely to smoke and 2.26× more likely to drink alcohol throughout the preg-
nancy [2]. Studies have also shown an increase in the rate of depression, suicide rates and
lack of attachment towards the child post-partum [25,26]. As a result, there were more
neonatal issues in women experiencing IPV [2]. For example, the increased rates of preterm
labour, intrauterine growth retardation and lower birth weight [2].
Chronic pain is defined as pain that persists or recurs for more than 3 months [27]. This
may be characterized by significant emotional distress (anxiety, frustration or depressed)
and/or functional disability (interference in activities of daily living) [27]. Chronic pain
is extremely expensive for the NHS and the indirect cost of back pain alone is estimated
to be over 10 billion pounds per annum for the UK [28]. Controlled studies have shown
that chronic pain is a common clinical health consequence of IPV, and the prevalence is
significantly increased in victims [29]. Women who were subject to IPV had an increase in
chronic pain symptoms such as back pain, pelvic pain and headaches [29,30]. The increase
was between 50–70% and was present in both the controlled studies and within the general
population [29,30]. It is theorised that the psychological trauma from domestic abuse
forms a complex biopsychosocial stress response that triggers the chronic pain [31]. As a
result, victims were more likely to develop chronic pain conditions such as chronic fatigue
syndrome and fibromyalgia [31].
1.7. Psychological Impact of DVA
Mental health issues are multifactorial and are associated with many life events
such as childhood abuse, daily stressors, martial separations, and negative life events [3].
However, there is a significant association between experiencing domestic violence abuse
and developing mental health issues [32]. Within the general population, victims who have
experienced domestic violence abuse are at increased risk of depression, post-traumatic
stress disorder (PTSD), substance abuse and anxiety [32]. The overall cost that domestic
violence has on the mental healthcare system within the UK is estimated to be GBP 176
million per year [21]. However, this is likely to be a massive underestimation as most DVA
is unrecognised [7].
Depression and PTSD are the most prevalent mental-health issue amongst victims [3].
PTSD is a chronic psychological disorder that occurs after exposure to traumatic events [33].
This is a potentially chronic impairing disorder characterized by re-experience and avoid-
ance symptoms [33]. Depression is a mood disorder that causes a persistent feeling of
sadness and loss of interest [34]. PTSD and depression cause a lower quality of life, worse
physical health outcomes and a reduced productivity in the workplace [35,36]. The ill-
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ness of mental health is responsible for 72 million working days lost and costs GBP 34.9
billion per year, with depression being one of the main causes [36]. A meta-analysis of
multiple studies shows the prevalence of depression amongst DVA victims is 47.6% and
the prevalence of PTSD is 63.8% [37].
Furthermore, an analysis of 10 different countries showed a direct correlation between
experiencing domestic violence and the rate of suicide attempts [38]. The meta-review
of 18 studies showed that women who have been subject to domestic violence have an
average suicide rate of 18% [21]. It is suggested that the association between IPV and
suicide attempts is stronger when there is physical violence involved because the physical
pain acts as a precursor to future suicide attempts [38].
1.8. The Role of Healthcare Professionals
Intimate Partner Violence (IPV) is a public health issue, and the World Health Or-
ganisation emphasises that healthcare professionals have an important role in identifying
domestic violence [6]. Women who are abused are frequently treated within health-care
systems, but they do not always present with obvious signs of trauma and are therefore
undetected [3].
A healthcare professional is in a position of trust and victims of domestic abuse are
more likely to contact health services than any other agency [39]. Healthcare may be
a survivor’s first or only point of contact with professionals [39]. Unfortunately, most
clinicians fail to identify domestic violence and are uncertain about referral pathways
after disclosure [7]. It should be stressed that it has been well documented that most
healthcare professionals are uncertain on how to deal with domestic abuse patients [7].
The success of general practitioners in recognising cases of domestic violence in the UK has
not been thoroughly investigated but is expected to be low [24]. An American study that
used primary care medical records showed that fewer than 10% of women experiencing
IPV were being identified by doctors [24]. It is therefore very important that healthcare
professionals are provided with the required training, knowledge and skills to handle
domestic violence.
1.9. Training Programme for Healthcare Professionals in DVA
As mentioned previously healthcare professionals are largely unaware of appropriate
interventions and have seldom received effective or, indeed, any training. Understand-
ing the impact of domestic violence on the victim, wider society and economy can help
highlight the importance of the issue of identification.
However, there is a need to present a case to show there is a link between implementing
an intervention programme and reducing the economic impact of DVA. This would help
to present a stronger case for the government to utilise our limited NHS budget into
intervention programmes. Therefore, the Identification and Referral to Improve Safety
(IRIS) programme will be discussed. IRIS is a training and support programme which
was first piloted in 2007 [10]. The main goal of IRIS was to address the shortcoming and
improve the response to domestic violence and abuse (DVA) in general practice [9].
1.10. Identification and Referral to Improve Safety (IRIS)—A Training and Support Programme
The primary objective of this report was to study the IRIS programme. Currently
the programme is implemented in primary care, in this project special attention will be
given to assess the possibility of introducing IRIS to secondary care. To this end, in the
following sections of this report, an attempt has been made to explore various aspects of
IRIS including:
• The history and background of IRIS.
• Review of available literature associated with IRIS.
• Discussion of randomised controlled trial of IRIS.
• Discussion of IRIS cost-effectiveness in primary care.
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• Future of IRIS-Exploring the potential benefit of implementing an adapted IRIS pro-
gramme into secondary care.
• Recommendation how to adapt the programme for secondary care.
• Suggestions for future research and studies with regards to IRIS.
1.11. The History and Background of IRIS
In 2007 the Medical Research Council piloted a trial into primary care called the
IRIS programme [10]. IRIS was the first European randomised controlled trial of an
intervention to improve the healthcare response to domestic violence and abuse [39]. It
aimed to determine the cost-effectiveness of a general practice based domestic violence
training and support programme and measure two outcomes: 1—the referral of women
to a domestic violence agency providing advocacy, and 2—the recording of disclosure of
domestic violence in the patient’s medical record [39].
IRIS is an intervention which provides domestic violence training to healthcare profes-
sionals and staff within primary care [9]. The programme consists of two two-hour training
sessions for clinicians and a single one-hour session for the administration team [10]. The
main aim of the programme is to improve healthcare response to domestic abuse [9]. This
is hoped to be achieved through two main methods; training on how to identify domestic
violence and education regarding the referral pathways to appropriate domestic violence
advocacy agents [9]. The sessions involve case studies and role-play to practise recognition
of DVA and communication skills training [39]. They are typically delivered by an advo-
cate educator and a clinical psychologist specialising in domestic violence or an academic
general practitioner [39].
The IRIS commissioning pack states that the training model ‘promotes clinical enquiry,
recognition of risk indicators, safety planning and holistic care for all patients’ [10]. The
training sessions are also followed by periodic contact with the practice in clinical meetings,
where anonymised data is collected regarding referral and disclosure rates of DVA [39].
Clinicians are also provided with telephone numbers and email exchanges for any enquires
or advice regarding DVA [39]. The one-hour training sessions with administrative staff pro-
vided IRIS information materials on the local DVA agency delivering the IRIS service [39].
In addition, there is a focus on issues of confidentiality and patient-safety for victims of
DVA [39]. Ongoing support is provided, and the initial training sessions are consolidated
via a domestic violence advocate educator [39]. Practises will also select a ‘local champion’
for the project who is a clinical member of staff and typically one of the GPs working in the
practise [39]. The local champion is often the practice GP safeguarding lead and helps to
integrate IRIS into the work of the practice [39].
It is important to note that clinicians are specifically trained to have a low threshold
for asking about domestic violence [39]. Although the IRIS intervention seeks to identify
all levels of domestic abuse, the IRIS advocacy educator only deals directly with patients
who are moderate risk or below [39]. Victims who are suspected to be at very high risk are
referred directly to Multi-Agency Risk Assessment Conferences (MARAC) [40].
2. Materials and Methods
A narrative review was conducted to create the background and introduction of the
topic by using resources from PubMed, Cochrane Library and Google scholar. The search
terms “Intimate partner violence”, “Domestic Violence”, “Domestic Violence and Abuse”,
“Identification and referral to improve safety programme” were utilized to find resources.
Although there was no systematic approach, reputable resources were prioritized where
possible. Below shows a summary of the different reputable resources utilized to create
our narrative review:
• The World Health Organisation for global definition prevalence of IPV
• United Nations for definitions of different forms of DVA
• Office for National Statistics for domestic abuse in England and Wales
• Crime and criminal justice police reports for domestic abuse in Scotland
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• Office of European Union for DVA and IPV statistics and costs
• National Violence Against Women Survey for data within the United States
The impact and cost-effectiveness of the IRIS programme was investigated by using
the publicly available IRIS randomised controlled trial data [7]. This is considered the gold
standard approach for data collection and analysis.
The effectiveness of the IRIS programme was assessed by comparing the proportion
of IPV patients identified and referred amongst general practices with and without the
IRIS intervention.
The cost-effectiveness was measured by quoting the cost of commissioning IRIS from
the official IRIS website and comparing the total cost to the National Health Service for the
practices who implemented or did not implement the intervention. The National Institute
for Health and Care Excellence standard for the cost-effectiveness threshold of GBP 20,000
was utilized as a benchmark.
3. Results
3.1. Randomised Controlled Trial of IRIS
The first training sessions of IRIS took place on the September of 2007 [9]. This was
part of IRIS trials being held in 24 GP practises around Hackney and Bristol [9]. The
trials were part of a randomised controlled test designed to assess the effectiveness of
implementing a training and support intervention for general practice teams [39]. The trial
measured the identification and referral rates for practises that had and had not received
the IRIS intervention [7].
The primary outcome of the trial was to measure the number of women aged 16+ re-
ferred to specialist domestic violence agencies [7]. This was tracked by using the electronic
medical records of the general practise [7]. This outcome was measured for 12 months
preceding the first training session and then for 12 months after completing the full train-
ing [7]. In addition, the pre-specified secondary outcome was the number of domestic
violence victims identified [7]. This was recorded using the same technique that was used
for the primary outcome [7].
Table 1 shows the number of recorded referrals and identifications of women experi-
encing domestic violence in general practise and domestic violence referrals received by
specialist agencies, 12 months after intervention [7].
Table 1. Data from randomised controlled trial of IRIS-2007.
Description Control Group Intervention Group
Number of eligible women per practise 3088 2945
Recorded referral in the general practise
electronic medical record 12 223
Recorded disclosure of domestic violence in
general practise electronic medical record 236 641
Overall referrals received by specialist
domestic violence agencies 40 238
The results show that IRIS training had a substantial impact on both the number
of referrals to domestic violence agencies and on the number of women identified who
were experiencing DVA [7]. The number of overall referrals, which includes referrals from
clinicians, other agencies and self-referrals, was seven-times higher in the intervention
practises [7]. The adjusted ratio shows a three-fold increase in the identification of victims
experiencing DVA in the intervention practises [7]. In addition, the intervention practises
had a combined total of 223 recorded direct clinician referrals which is a 22-fold increase in
the referral rate compared to the control practises [7]. However, the 223 recorded referrals
overestimate the number of direct referrals sent by clinicians, at least in the intervention
practises, because domestic violence agencies only received 184 [7]. In addition, it is
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important to note that not all the women referred to the agency received help [7]. Out of
the 184 direct referrals received, 30% of the women could not be contacted [7]. Despite
this, IRIS proved to be a huge success in the trials results and the early statistical analysis
showed an increase in identification and referrals by the programme [7]. A total of 57%
of the women who were put in contact with an advocate were given an onward referral
within the agency and of those women, 63% accepted it [39]. As a result, since this trial,
IRIS has been implemented in over 800 GP practises across the UK [41].
3.2. Discussion of IRIS Cost-Effectiveness
The official IRIS website states that in order to commission the IRIS model, a financial
investment of approximately GBP 70,000 is required for year one [13]. In addition, the
hourly advocate educator costs are estimated to be GBP 34 [39]. A calculation from the
Sullivan trial showed an average of 57 h required per onward referral to an advocacy
agency [39]. However, the costs did not take into account the amount of time spent by
doctors to identify and refer patients [39].
To analyse whether IRIS is beneficial from an economic standpoint, it is important to
highlight how the NHS deems an intervention as cost-effective. The National Institute for
Clinical Excellence (NICE) is an organisation that makes recommendations about which
treatments and interventions should be available on the NHS in England and Wales [42].
The aim of NICE is to use the resources made available to the NHS by the government
efficiently, thus providing the highest quality of care [43]. Whether a treatment is authorised
by NICE is based on relative cost effectiveness [43]. Cost-effectiveness is calculated using a
measurement called cost quality adjusted life year (QALY) [43]. QALY is a complicated
measurement that takes into account both the length of life gained and the improvement
in quality of life [43]. NICE considers any intervention that costs the NHS less than GBP
20,000 per QALY gained as cost-effect [44]. Although there has never been a fixed threshold
set and the cost per QALY is supposedly used to only aid their judgement, there are very
few treatments offered on the NHS that costs above GBP 30,000 per QALY [45].
A cost-effective analysis was conducted on IRIS by using the randomised controlled
trial data and analysing this with the Marvok Model [39]. The Marvok Model is able
to carry out statistical analysis to predict the probability of an event based on previous
data [39]. The Marvok Model was used to predict costs and outcomes in a hypothetical
cohort of women who received the IRIS intervention and those who did not [39]. This
calculated the QALY and costs from both a UK National Health Service perspective and a
societal perspective [39].
The results showed that IRIS is extremely likely to be cost-effective from both per-
spectives and had many long-term cost benefits [39]. The analyses demonstrated that the
societal cost savings per woman was GBP 37 per year [39]. When only NHS costs were
accounted for, the cost savings were GBP 1.07 per woman per year [39]. This averages to
saving GBP 3155 per practice in the UK per year [39]. The gap between societal cost savings
and NHS cost savings is due to the fact that NHS cost savings do not include money
saved within the criminal justice system, employment output and social servicing [39].
Even when excluding all of these societal cost benefits, the sensitivity analysis showed
that in 78% of model replications the intervention was under the NICE threshold of GBP
20,000 per QALY [39].
A separate study carried out in 2018 utilised updated real-world data to analyse the
cost-effectiveness of IRIS [41]. The data was obtained from six sites across England which
has been running IRIS for at least 2 years [41]. The same methods which were used to
analyse the randomised controlled trial were used to analyse this set of data [41]. The
results showed that IRIS was cost-effective in 61% of simulations using the QALY threshold
of GBP 20,000 [41].
It should however be emphasised that, in the broader societal perspective, the annual
projected savings from implementing IRIS intervention is huge [39]. It is important to
note that the actual estimation of cost-benefit is likely to be much higher, as the analysis
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did not take into consideration the impact of helping children who are exposed to a DVA
environment [39]. A household with DVA is a major risk to children and it is estimated that
75% of DVA incidents are witnessed by children [13]. Children who live in a household with
DVA are 14 times more likely to be a victim of domestic violence and 15 times more likely
to be a perpetrator of DVA when older [46]. In addition, they are more likely to engage in
high-risk behaviours such as excess alcohol drinking, smoking and illicit substances [46].
In conclusion, the analysis of IRIS reports and randomised controlled trials show that
there is clear evidence of cost-effectiveness of the IRIS programme in primary care [39].
This makes a strong economical case to use an adapted version of IRIS and implement this
into secondary care.
4. Discussion
4.1. Introducing IRIS into Secondary Care
The need to introduce an adapted version of IRIS in the secondary care is also very
self-evident. Most clinicians in the secondary care setting have no training regarding
domestic violence. It is therefore essential that the healthcare professionals are provided
with the required training, knowledge and skills to face the very difficult and sensitive
issue of domestic violence.
For the last part of this project, an attempt will be made to conduct a short feasibility
study of introducing IRIS into secondary care, namely into fracture clinic. Suggestions
will be made on how IRIS can be adapted for implementation in the fracture clinics. The
reasons for selecting the fracture clinic are outlined. Recommendations will also be offered
with regards to initiating a possible pilot study. A method for collecting accurate clinical
data and analysing results is also proposed.
4.2. Why the Fracture Clinic?
Intimate partner violence is the leading cause of non-fatal injury to women world-
wide [47]. Orthopaedic surgeons are therefore in the best place to play an important role
in the identification of DVA victims. Musculoskeletal injuries, which are often seen by or-
thopaedic surgeons in fracture clinics, are the second most common physical manifestation
for victims of IPV [47].
A systematic review in orthopaedic fracture clinics of Canada, USA, The Netherlands,
Denmark and India showed that one in six women presenting to orthopaedic clinics have
experienced DVA within the past year [47]. In addition, one in 50 who attends the clinics
has sustained injuries as a direct consequence of IPV [47]. This shows that there is huge
potential for the orthopaedic and fracture clinics to help make a difference.
4.3. Orthopaedic Presentation of IPV
As part of this project, a relatively detailed survey of available research about Or-
thopaedic presentations of IPV was carried out. However, it appears the number of research
articles regarding Orthopaedic injuries associated with domestic abuse is very limited. Sev-
eral observational studies have investigated variables associated with domestic violence. A
few have evaluated the associated injuries. The head and neck injuries associated with the
experience of domestic violence, have been the subject of several studies.
In contrast, little information is available about the prevalence of musculoskeletal
injuries. However, the paper titled “Musculoskeletal Manifestations of Physical Abuse
After Intimate Partner Violence” by Mohit Bhandari and his co-writers may help us to gain
an insight into the issue [48]. From 1 January 2002, through 31 December 2003, all female
survivors of intimate partner violence, who were referred to the Minnesota Domestic Abuse
Program, were identified [48]. The findings were published in the abovementioned paper.
In order to have a more detailed picture of orthopaedic injuries associated with IPV, it is
felt it would advantageous to carry out a full review of the findings of Minnesota research.
The data from the paper were extracted, reanalysed and presented in the following table
and graphs:
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discrepancies in the calculation of numbers or percentages solely lie with the writer of this
project. Figures 1–6 were also created for this project. The responsibility with regards the
suitability, appropriateness and presentation of these graphs are also with the writer of
this project.
Table 2. Epidemiology of injuries related Intimate partner violence.
Type of Injury Number of Occurrences (n = 144) Proportion (%)
Head and Neck 58 40%
Black eyes 14 10%
Loss of vision 1 1%
Broken teeth 4 3%
Fractured nose 9 6%
Fractured mandible 8 6%
Loss of hearing 2 1%
Head injury/concussion 15 10%
Coma 2 1%
Upper airway problem 3 2%
Musculoskeletal 40 28%
Sprains 21 15%
Neck Sprain 6 4%
Wrist Sprain 2 1%
Back sprain 7 5%
Knee sprain 2 1%
Ankle sprain 2 1%
Foot sprain 2 1%
Fracture/Dislocation 17 12%
Fingers 11 8%
Shoulder dislocation 3 2%
Humerus fracture 1 1%
Clavicle fracture 1 1%
Pelvic fracture 1 1%







Stab wounds 3 2%
Gunshot wounds 1 1%
Bite wounds 2 1%
Chest 11 8%
Chest contusion 3 2%
Fracture ribs Scratches 8 6%
Gastrointestinal 3 2%
Epigastric tenderness 2 1%
Splenic Injury 1 1%
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opens a new window of opportunity to start trials into secondary care and collect the rel-
evant data. This will enable us to explore the impact of a DVA intervention programme 
within a secondary care environment. 
The Salford orthopaedic hospital as the leading fracture clinic in North West appears 
to be ideal location to conduct any potential trials. The pilot study should aim to introduce 
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Table 2 and Figure 1 above demonstrate that musculoskeletal injuries are the second
most common physical manifestation of IPV, with these injuries accounting for 28% of all
physical injuries associated with IPV. Figure 3 shows that the most common musculoskele-
tal injuries seen by orthopaedic surgeons within fracture clinics were sprains, fractures,
dislocations and foot injuries [48]. Sprains accounted for over 52% of the total, with back
and neck sprains being the most common manifestation [48]. Fractures and dislocations
accounted for just below 43% of injuries, with the fingers being the most common loca-
tion [48]. However, it is important to be aware of other common physical manifestations of
physical abuse. For example, Figure 2 displaying that head and neck injuries accounted
for 40% of the total, with black eyes and concussions being extremely common amongst
victims [48].
4.3.1. Proposal—Introducing IRIS into Fracture Clinics
At the moment, the effectiveness and appropriateness of implementing IRIS into frac-
ture clinics is unknown. It is therefore important that, first, the suitability, practically and
viability of IRIS for secondary care is fully evaluated. The results from the implementation
of IRIS in primary care should only form the bases of such assessment. The available
information relates to the data which were obtained from GP practises.
The secondary care would be a very a different environment. It would be unreasonable
to extrapolate the same data from GP practises and apply it to secondary care. This opens
a new window of opportunity to start trials into secondary care and collect the relevant
data. This will enable us to explore the impact of a DVA intervention programme within a
secondary care environment.
The Salford orthopaedic hospital as the leading fracture clinic in North West appears
to be ideal location to conduct any potential trials. The pilot study should aim to introduce
IRIS into the clinic and collect the relevant data to assess the suitability of the programme.
4.3.2. Recommendations—IRIS Pilot Study in Salford Fracture Clinic
It is recommended that before commencing a trial, a full and comprehensive feasibility
study is conducted. The study should offer a solution on how IRIS can be adapted for
implementation into fracture clinics. A practical method for collecting and analysing the
clinical data should also be assessed and agreed.
A similar method of data collection to the IRIS randomised controlled trial carried
for the primary care could be considered for the Salford fracture clinic. This may involve
obtaining a baseline number of IPV identifications and referrals for 12 months before imple-
menting the intervention. This will act as the control group. For the 12 months following
the implementation, there can be data collection on identification and referral rates. The
results can then be reassessed using statistical analysis to evaluate the effectiveness and the
impact of the intervention.
4.3.3. The Potential Hurdle and Challenges of Implementing IRIS into Fracture Clinic
It must be mentioned that the attitude of healthcare professionals towards intimate
partner violence is an issue which needs to be addressed. The investigation performed at
the Division of Orthopaedic Surgery, Department of Surgery, McMaster University, was
aimed to identify the perceptions, attitudes, and knowledge of Canadian orthopaedic
surgeons with regard to intimate partner violence [49]. It was found that misconceptions
were perpetuated by surgeons who believed that inquiring about intimate partner violence
was an invasion of the victim’s privacy, that investigating intimate partner violence was
not part of their duty, that victims choose to be a victim, and that victims play a proactive
role in causing their abuse [49]. Furthermore, it was concluded that discomfort with the
issue and lack of education were the main reasons for misconceptions among Canadian
orthopaedic surgeons about intimate partner violence [49].
A small-scale study was also carried out to explore staff perception of IPV within the
Salford Fracture Clinic [50]. The study showed the following: less than half the doctors and
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nurses understood the prevalence of IPV, less than 20% of nurses and doctors knew the
common physical manifestations of IPV and the most common reason for not asking about
IPV was not wishing to offend the patient [50]. Other common reasons for not querying
IPV was that they assumed it was already done in A+E or that they did not think it is
necessary [50]. These results display a lack of understanding and many misconceptions
regarding IPV.
Other issues that need to be taken into consideration may include: allocation of the
required staff, cost and time. This includes details such as staff turnover, supervision, clini-
cal environment, confidentially; all of which need to be considered before implementing
a trial.
Furthermore, the hospital environment is different to general practise. There is a rapid
turnover of staff, both amongst the clinicians and the administrative workers. As a result,
members of staff who carry out the IRIS training may leave or move elsewhere before
the trial has been completed. The replacement would be unlikely to have the appropriate
training. The accuracy and validity of a pilot study is based on consistent and reliable
data. To collect accurate data, the staff must be fully committed and undergo the required
training. However, the orthopaedics and fracture clinics are a big environment with a
much larger volume of employers and patients than GP practises. This will make the job of
tracking who has carried out the appropriate training and who has not difficult.
Evaluating the potential cost of performing an IRIS trial in the fracture clinic may
prove to be extremely challenging. The cost of IRIS training and employing an advocacy
educator needs to be adjusted based on the number of staff and patients in the clinic.
Naturally, there are more patients and staff within the clinic environment and so it would
be more expensive to carry the trial out. However, in order to apply for funding, an
estimation of the overall costs needs to be done.
Finally, for this intervention programme to be implemented successfully there needs
to be a suitable local champion. This person has an essential role as they help to integrate
the training programme into the clinic. However, selecting a suitable local champion for the
fracture clinics will be challenging. Ideally, the selected person needs to be an orthopaedic
consultant, similar to how GPs are chosen as local champions within each practice. In
addition, they need to have the time and willingness to undergo the required training and
put the extra time investment that comes from being local champion.
5. Conclusions
The implementation of the IRIS programme in general practice has proved to be cost
effective. Introducing an adapted version of the IRIS programme into secondary care could
also address the reported lack of specialist training within the environment. Fracture clinics
are at the forefront of dealing with the consequences of domestic violence abuse—and
therefore would appear a natural extension to the existing IRIS programme in primary care.
It will undoubtedly help to provide a better quality of care for the victims of IPV. However,
implementing a cost-effective IRIS programme into the secondary care environment will
create a range of complex and difficult challenges.
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